Anne Uyei
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Colorectal Cancer Treatments and Studies
- Cancer Risks and Factors
-
- Immunotherapy and Immune Responses
Papers in
- Co-authors
- Paolo A. Ascierto (3 shared papers)Grant A. McArthur (3 shared papers)Светлана Проценко (2 shared papers)Daniil Stroyakovskiy (2 shared papers)Thomas Eigentler (2 shared papers)Caroline Robert (2 shared papers)Helen Gogas (2 shared papers)Lev Demidov (2 shared papers)
- Journals
- Blood (4 papers)Cancer (2 papers)Journal of Clinical Oncology (1 paper)Clinical Breast Cancer (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Anne Uyei
15 papers receiving 775 citations
Anne Uyei's Hit Papers
Peers
Comparison fields: 5 of 48
- Oncology 482
- Immunology 135
- Cancer Research 88
- Pathology and Forensic Medicine 77
- Molecular Biology 281
Countries citing papers authored by Anne Uyei
This map shows the geographic impact of Anne Uyei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Uyei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Uyei more than expected).
Fields of papers citing papers by Anne Uyei
This network shows the impact of papers produced by Anne Uyei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Uyei. The network helps show where Anne Uyei may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Uyei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2020 | 453 |
| 2 | 2005 | 64 | |
| 3 | 2006 | 57 | |
| 4 | 2006 | 42 | |
| 5 | 2018 | 38 | |
| 6 | 2017 | 31 | |
| 7 | 2007 | 26 | |
| 8 | 2017 | 25 | |
| 9 | 2021 | 18 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 7 | |
| 12 | 2020 | 7 | |
| 13 | 2011 | 6 | |
| 14 | 2021 | 3 | |
| 15 | 2020 | 2 |
About Anne Uyei
Anne Uyei is a scholar working on Genetics, Oncology, Hematology, Molecular Biology and Genetics, having authored 15 papers that have together received 786 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (4 papers), Acute Myeloid Leukemia Research (3 papers), BRCA gene mutations in cancer (3 papers), Melanoma and MAPK Pathways (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (482 citations), Immunology (135 citations), Cancer Research (88 citations), Pathology and Forensic Medicine (77 citations) and Molecular Biology (281 citations). Anne Uyei has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Paolo A. Ascierto, Grant A. McArthur, Светлана Проценко, Daniil Stroyakovskiy, Thomas Eigentler, Caroline Robert, Helen Gogas, Lev Demidov, Georgy M. Manikhas and Yibing Yan. Their work appears in journals such as Blood, Cancer, Journal of Clinical Oncology, Clinical Breast Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.